Comparison 1. Albiglutide versus placebo.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 HbA1c (%)			Other data	No numeric data
2 HbA1c ‐ with plot	1		Mean Difference (IV, Random, 95% CI)	Subtotals only
2.1 ALBI 30 mg weekly	1	79	Mean Difference (IV, Random, 95% CI)	‐0.7 [‐1.07, ‐0.33]
2.2 ALBI 30 mg every 2 weeks	1	82	Mean Difference (IV, Random, 95% CI)	‐0.62 [‐1.06, ‐0.18]
3 HbA1c < 7%			Other data	No numeric data
4 Hypoglycaemia			Other data	No numeric data
5 Weight change ‐ with plot	1		Mean Difference (IV, Random, 95% CI)	Subtotals only
5.1 ALBI 30 mg weekly	1	79	Mean Difference (IV, Random, 95% CI)	‐0.7 [‐1.89, 0.49]
5.2 ALBI 30 mg every 2 weeks	1	82	Mean Difference (IV, Random, 95% CI)	‐0.9 [‐2.08, 0.28]
6 Weight change (kg)			Other data	No numeric data
7 Adverse events			Other data	No numeric data
8 Blood pressure (mm Hg)			Other data	No numeric data
9 Fasting plasma glucose (mmol/L)			Other data	No numeric data
10 Lipid profiles			Other data	No numeric data
11 Beta‐cell function			Other data	No numeric data
12 Subgroups			Other data	No numeric data